Poly(2-oxazoline)- and Poly(2-oxazine)-Based Self-Assemblies, Polyplexes, and Drug Nanoformulations-An Update

Area of Science:

• Polymer Chemistry
• Materials Science
• Biomedical Engineering

Background:

• Poly(2-oxazoline)s (POx) and poly(2-oxazine)s (POx) were historically niche research areas.
• Recent clinical trials of POx-based drug conjugates have spurred significant interest.
• The chemical and structural diversity of these polymers is rapidly expanding.

Purpose of the Study:

• To review recent advancements in macromolecular self-assemblies and non-covalent drug delivery systems using POx and POx.
• To highlight the untapped potential of these polymers in drug formulation.
• To discuss the impact of the extensive synthetic toolbox on this dynamic field.

Main Methods:

• Literature review of poly(2-oxazoline) and poly(2-oxazine) research.
• Focus on self-assemblies, polyplexes, and nanoformulations for drug delivery.
• Analysis of synthetic methodologies and their implications for drug conjugate development.

Main Results:

• Significant expansion of the synthetic toolbox for POx and POx in recent years.
• Demonstrated potential in creating advanced drug delivery systems like polyplexes and nanoformulations.
• Promising clinical outcomes for early-stage POx-based drug conjugates.

Conclusions:

• The field of POx and POx in drug delivery is highly dynamic with substantial untapped potential.
• The extensive synthetic versatility is a key driver for innovation in self-assemblies and nanoformulations.
• Continued research is expected to further elucidate the safety and therapeutic applications of these polymers.